Organon & Co. OGN
NYSE · United States · Health Technology
$13.71+0.01 (+0.07%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-31 | 0.85 | 0.91 | -6.6% | $1.60B | 0.0% | +0.1%$13.55→$13.56 |
| Q1 2026 | 2026-04-30 | 0.66 | 0.82 | -19.5% | — | — | -0.4%$13.34→$13.29 |
| Q4 2025 | 2026-02-12 | 0.63 | 0.73 | -13.7% | — | — | -3.9%$7.69→$7.39 |
| Q3 2025 | 2025-11-10 | 1.01 | 0.93 | +8.6% | — | — | +10.9%$6.78→$7.52 |
| Q4 2024 | 2025-02-13 | 0.90 | 0.87 | +3.4% | — | — | — |
| Q4 2023 | 2024-02-15 | 0.88 | 0.83 | +6.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.